Pierre Lestage

Chief Executive Officer at NeribiOm

Pierre Lestage, currently work as the Chief Executive Officer at NeribiOm, a microbiome drug discovery company looking for original neurosynbiotics as innovative Live Biotherapeutic Products for neurological and psychiatry diseases. He holds a PhD in neuropharmacology from Lyon university. He has more than 35 years of experience in managing research teams, programs and external collaborations in neuropsychopharmacology within pharmaceutical industry. From 1998 to 2015 he was head of neuropharmacology drug discovery research within Servier. During his carrier in pharmaceutical industry, about thirty drugs have been selected for preclinical development and eight of them have been tested into clinical trials.

He is the author or co-author of more than 80 papers published in in peer-reviewed journals and he is the co-inventor of more than 60 patents (first depositions) in the field of therapeutic treatments for a large spectrum of CNS diseases.


Case Study: Gut brain axis and neurological diseases.

Other Speakers from the Gut Week Summit

Lucie Lingrand

Product Manager at Lallemand Health Solutions

Rohan F. Hastie

President & Chief Executive Officer at Metabolon

Jane A. Foster

Associate Professor at McMaster University